Success! In Clinical Laboratory Science – Hemostasis Practice Test

Session length

1 / 20

A platelet aggregation agent that characteristically yields a biphasic curve in optimal concentration is?

Arachidonic acid

Collagen

Epinephrine

The biphasic pattern seen with this agent comes from two sequential ways it activates platelets. At an optimal concentration, epinephrine first stimulates platelets directly through adrenergic receptors, causing an initial wave of aggregation. As platelets activate, they release dense-granule contents like ADP and other mediators, which then drive a second, second-wave aggregation. The result is two distinct peaks in the aggregation curve.

Other agents tend to produce a single, monotonic aggregation response. Arachidonic acid acts through the thromboxane A2 pathway to give a more uniform rise, collagen generally yields a strong single-phase curve, and ristocetin causes vWF-dependent agglutination with a different pattern altogether. That dual, two-phase response is the hallmark of epinephrine in platelet aggregation testing.

Ristocetin

Next Question

Find the option that is right for you!

All options are one-time payments.

$25.99

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
👑$59.99 $171.99 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $171.99 usd value for $59.99! You save $106!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$15.99 $24.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy